Treatment of leukemic cells with oligonucleotides encoding the genomic c-MYC quadruplex-forming sequence, Pu27, induces growth arrest and cell death in several leukemic cell lines by inhibiting c-MYC expression.[20] This observation was the first report of selective cancer cell killing by a genomic DNA sequence. This evidence concerns the gene MYC and cancer.